NEJM challenge seeks to demonstrate clinical trial data sharing's potential

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/anyaberkut)
(Image: iStock/anyaberkut)

Related tags Clinical trial data Health care

Clinical trial data sharing continues to be a contentious topic in the industry, so in an attempt to demonstrate its potential, the New England Journal of Medicine (NEJM) is sponsoring the SPRINT Data Analysis Challenge.

Over recent years, many questions have arisen as to who owns clinical trial data, putting the issue of data sharing at a critical turning point​,” NEJM editor-in-chief Dr. Jeffrey Drazen, told in a statement.

The SPRINT Data Analysis Challenge​ tasks individuals and groups to identify a novel scientific or clinical result after analyzing the dataset underlying the SPRINT article​: A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

The challenge culminates with the Aligning Incentives for Sharing Clinical Trial Data summit in April.

“We believe this will be the start of an ongoing conversation among the three key constituencies – clinical trialists, data analysts, and patient participants — to whom data matters most​,” said Drazen.

The community has an opportunity to shape the future of clinical trial data sharing, and the SPRINT Challenge is a step toward that goal,​” he added.

Isaac Kohane, M.D. Ph.D., Chair of Harvard Medical School’s Department of Biomedical Informatics and Co-Chair of the SPRINT Challenge described the challenge as “a catalyst for a new framework for data sharing​.”

The challenge is open to health care professionals, researchers, and scientists.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more